-+ 0.00%
-+ 0.00%
-+ 0.00%

ABELZETA RECEIVES FDA RMAT AND FAST TRACK DESIGNATIONS FOR PRIZLON-CEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA

Reuters·11/10/2026 13:33:15